Royal Bank of Canada’s Olema Pharmaceuticals OLMA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $501K | Buy |
117,804
+95,865
| +437% | +$408K | ﹤0.01% | 4140 |
|
|
2025
Q1 | $83K | Sell |
21,939
-1,179
| -5% | -$4.46K | ﹤0.01% | 4977 |
|
|
2024
Q4 | $135K | Sell |
23,118
-485
| -2% | -$2.83K | ﹤0.01% | 4685 |
|
|
2024
Q3 | $282K | Buy |
23,603
+10,972
| +87% | +$131K | ﹤0.01% | 4130 |
|
|
2024
Q2 | $137K | Buy |
12,631
+12,012
| +1,941% | +$130K | ﹤0.01% | 4678 |
|
|
2024
Q1 | $7K | Sell |
619
-7,526
| -92% | -$85.1K | ﹤0.01% | 5895 |
|
|
2023
Q4 | $114K | Buy |
8,145
+3,637
| +81% | +$50.9K | ﹤0.01% | 5010 |
|
|
2023
Q3 | $56K | Buy |
4,508
+1,707
| +61% | +$21.2K | ﹤0.01% | 5232 |
|
|
2023
Q2 | $25K | Buy |
2,801
+2,443
| +682% | +$21.8K | ﹤0.01% | 5639 |
|
|
2023
Q1 | $1K | Buy |
358
+276
| +337% | +$771 | ﹤0.01% | 6525 |
|
|
2022
Q4 | $0 | Buy |
82
+8
| +11% | – | ﹤0.01% | 7025 |
|
|
2022
Q3 | $0 | Buy |
+74
| New | – | ﹤0.01% | 7167 |
|
|
2022
Q2 | – | Sell |
-1,576
| Closed | -$7K | – | 7052 |
|
|
2022
Q1 | $7K | Sell |
1,576
-118,111
| -99% | -$525K | ﹤0.01% | 6628 |
|
|
2021
Q4 | $1.12M | Buy |
119,687
+117,098
| +4,523% | +$1.1M | ﹤0.01% | 3220 |
|
|
2021
Q3 | $71K | Buy |
2,589
+1,190
| +85% | +$32.6K | ﹤0.01% | 5435 |
|
|
2021
Q2 | $39K | Buy |
1,399
+298
| +27% | +$8.31K | ﹤0.01% | 5707 |
|
|
2021
Q1 | $37K | Buy |
+1,101
| New | +$37K | ﹤0.01% | 5575 |
|